Patent · US Active

Composition for modifying myocardial infarction expansion

US9775930B2 · kind B2 · utility

14Cited by
262References
6Claims
0Family size

Assignees

Inventors

Key dates

Filing dateApr 13, 2015
Grant dateOct 3, 2017
Priority date
Expiry dateApr 13, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2430/20
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A bioscaffolding can be formed within a post-myocardial infarct region sufficient to cause attenuation of a rate of myocardial infarct expansion. A bioscaffolding may further be formed in the post-myocardial infarct region to cause an increase in posterior left ventricular wall thickness. The gel or bioscaffolding can be formed from a mixture of gel components of different gelation systems. For example, a bioscaffolding can be formed by mixing at least two different components of at least two different two-component gelation systems to form a first mixture and by mixing at least two different components (other than the components that make up the first mixture) of the at least two different two-component gelation systems to form a second mixture.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.